BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 990180)

  • 1. Utilization of a new strength citrate anticoagulant during centrifugal plateletpheresis. I. Assessment of donor effects.
    Mishler JM; Janes AW; Lowes B; Farfan C; Emerson PM
    Br J Haematol; 1976 Nov; 34(3):387-94. PubMed ID: 990180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utilisation of a new strength citrate anticoagulant during centrifugal plateletpheresis. III. Assessment of in vitro platelet metabolism.
    Zitko M; Reuter H; Borberg H; Mishler JM
    Vox Sang; 1979; 36(6):347-52. PubMed ID: 494571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utilization of a new strength citrate anticoagulant during centrifugal plateletpheresis. II. Assessment of in vitro platelet function.
    Mishler JM; Borberg H; Reuter H; Gross R
    Blut; 1977 Mar; 34(3):237-41. PubMed ID: 843628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased ionized calcium during therapeutic plasma exchange pheresis and platelet pheresis.
    Morse EE; Hohnadel DC; Genco P; Katz AJ
    Johns Hopkins Med J; 1980 Jun; 146(6):260-3. PubMed ID: 7382251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citrate anticoagulants for plateletpheresis.
    Huestis DW; Fletcher JL; White RF; Price MJ
    Transfusion; 1977; 17(2):151-5. PubMed ID: 850933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plateletpheresis with the IBM model 2997. I. Effects of ACD, NIH formula B on selected donor indices.
    Mishler JM; Lund P; Borberg H
    Vox Sang; 1980; 38(1):36-9. PubMed ID: 7376565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of combined platelet and leukapheresis on the blood coagulation system.
    Kisker CT; Strauss RG; Koepke JA; Maguire LC; Thompson JS
    Transfusion; 1979; 19(2):173-7. PubMed ID: 432930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of hydroxyethyl starch to improve granulocyte collection in the Latham blood processor.
    Huestis DW; White RF; Price MJ; Inman M
    Transfusion; 1975; 15(6):559-64. PubMed ID: 53922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of ionized magnesium measurement for monitoring of citrate-anticoagulated plateletpheresis.
    Mercan D; Bastin G; Lambermont M; Dupont E
    Transfusion; 1997 Apr; 37(4):418-22. PubMed ID: 9111280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pH and concentration of sodium citrate anticoagulant on platelet aggregation measured by light transmission aggregometry induced by adenosine diphosphate.
    Germanovich K; Femia EA; Cheng CY; Dovlatova N; Cattaneo M
    Platelets; 2018 Jan; 29(1):21-26. PubMed ID: 28643541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plateletpheresis using the haemonetics model 30 cell separator.
    Nusbacher J; Scher ML; MacPherson JL
    Vox Sang; 1977 Jul; 33(1):9-15. PubMed ID: 883246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of washed platelets from non-anticoagulated human blood.
    Bowry SK; Müller-Berghaus G
    Thromb Res; 1986 Sep; 43(6):621-33. PubMed ID: 2945282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sodium citrate and acid citrate dextrose solutions on cell counts and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel.
    Giraldo CE; Álvarez ME; Carmona JU
    BMC Vet Res; 2015 Mar; 11():60. PubMed ID: 25889052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrate anticoagulation and divalent cations in hemodialysis.
    Janssen MJ; Huijgens PC; Bouman AA; Oe PL; van der Meulen J
    Blood Purif; 1994; 12(6):308-16. PubMed ID: 7865189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of citrate effects during plateletpheresis in normal donors.
    Bolan CD; Greer SE; Cecco SA; Oblitas JM; Rehak NN; Leitman SF
    Transfusion; 2001 Sep; 41(9):1165-71. PubMed ID: 11552076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Function and morphology of platelets produced for transfusion by intermittent-flow centrifugation plateletpheresis or combined platelet-leukapheresis.
    Maguire LC; Henriksen RA; Strauss RG; Stein MN; Goedken MM; Echternacht B; Koepke JA; Thompson JS
    Transfusion; 1981; 21(1):118-23. PubMed ID: 6162254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole blood storage in citrate and phosphate solutions containing half-strength trisodium citrate: cellular and biochemical studies.
    Mishler JM; Darley JH; Cederholm-Williams S; Wright G
    J Pathol; 1978 Mar; 124(3):125-39. PubMed ID: 722376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory and clinical effects of the infusion of ACD solution during plateletpheresis.
    Olson PR; Cox C; McCullough J
    Vox Sang; 1977 Aug; 33(2):79-87. PubMed ID: 883248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined platelet-leukapheresis: a technique for preparing separate platelet and granulocyte-platelet units from single donors.
    Strauss RG; Goedken MM; Maguire LC; Koepke JA; Thompson JS
    Transfusion; 1979; 19(2):206-9. PubMed ID: 432933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Play of Citrate Infusion with Calcium in Plateletpheresis Donors.
    Lokhande T; Thomas S; Kumar G; Bajpai M
    Indian J Hematol Blood Transfus; 2021 Apr; 37(2):295-301. PubMed ID: 33867737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.